华海药业：关于获得药品注册证书的公告

Core Viewpoint - Huahai Pharmaceutical has received the drug registration certificate for Maleate Trimebutine Tablets from the National Medical Products Administration, indicating a significant regulatory approval for the company [2] Group 1 - The company announced the receipt of the drug registration certificate on February 24 [2] - The approval is for Maleate Trimebutine Tablets, which suggests potential market entry and revenue generation opportunities for the company [2]